William P. Quinn, President, CEO and CFO at Bolt Biotherapeutics, sold BOLT on Sep 18, 2026
Data as of Oct 16
▼ SELL$29.6K9,132 shares at $3.24William P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.
- Traded
- Sep 18, 2026
- Disclosed
- Sep 21, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
BOLT since disclosure
+11.4%
after the sale
Similar stocks (XLV) since disclosure
+4.6%
XLV — its sector index fund
Change in closing price from Sep 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$21.7Kdisclosed Sep 21 · filed 4 days after the trade
- ▼ SELLWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$7.1Kdisclosed Sep 21 · filed 5 days after the trade · late
- ▲ BUYWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$2.5Kdisclosed Sep 21 · filed 108 days after the trade · late